lumicks.com is built with Webflow, hosted on Webflow Hosting behind Cloudflare. It measures traffic with Google Tag Manager and Microsoft Clarity. It sends email through Amazon SES.
| Technology | Version | First seen |
|---|---|---|
| CMS & Site Builders2 | ||
| – | 16 Nov 2026 | |
| – | 16 Nov 2026 | |
| WordPress Plugins1 | ||
| – | 16 Nov 2026 | |
| JavaScript Frameworks & Libraries3 | ||
| – | 16 Nov 2026 | |
| Frontend Build Tools & CSS2 | ||
| – | 16 Nov 2026 | |
| – | ||
| Web Servers, Languages & Backend Frameworks1 | ||
| – | 16 Nov 2026 | |
| CDN & Hosting2 | ||
| – | 16 Nov 2026 | |
| Analytics & Tag Management2 | ||
| – | 16 Nov 2026 | |
| Advertising & Affiliate Tracking2 | ||
| – | 16 Nov 2026 | |
| Transactional Email2 | ||
| – | 16 Nov 2026 | |
| Accessibility1 | ||
| – | 16 Nov 2026 | |
| Authentication & Identity1 | ||
| 1 | 16 Nov 2026 | |
| Consent Management & Privacy1 | ||
| – | 16 Nov 2026 | |
| Fonts & Icon Fonts2 | ||
| – | 16 Nov 2026 | |
| Security, WAF & Bot Protection1 | ||
| – | 16 Nov 2026 | |
| Video, Audio & Media Delivery1 | ||
| – | 16 Nov 2026 | |
Registration from the registry's RDAP record, the certificate the site serves, and its rank in public traffic lists.
The crew hasn’t read this site’s colors yet. We read a palette when we capture a site’s screenshot, busiest sites first. Meanwhile, browse palettes from other sites.
What the homepage's first heading and body text render in, read from the browser's computed styles, and where the font files come from.
Counted from every stack change we've recorded: of the sites we watched running one of this site's tools, how many went on to add another. A pattern across sites, not a forecast for this one.
lumicks-com.mail.protection.outlook.comns-169-a.gandi.netns-45-b.gandi.netns-80-c.gandi.netatlassian-domain-verification=BwuYdBvJS4unGT+npcWFRuQonC2SR7mKLi3zNCqHS0gL8Qsh92+n6E5/Con0GSuZv=spf1 a include:spf.protection.outlook.com include:_spf.atlassian.net include:amazonses.com include:_spf.salesforce.com include:one.zoho.eu ip4:93.119.0.14 ip6:2a01:7c8:bb0a:d:5054:ff:fea0:f6fb -allsite24x7-signals-domain-verification=7ecc0bcba521a7ee84323de067395a5dgoogle-site-verification=7wZ0G3NAmiL4FRj3qVFnv_P1wogaSiyFhDVT1c8z758zoho-verification=zb51218875.zmverify.zoho.eusending_domain970813=202cd93989182055a799878ec02f397e9a11b058bb63227933a5b8d580c8902dgoogle-site-verification=22wowl19jsCWCbYZg7OBL_Ndzc_JwRnyhiIIpxkvb3Mpardot970813=eae8a998722af8c5fd10ef691a5d7a4da6de6023ecc0174dd572100591a7b147v=DMARC1; p=reject; rua=mailto:dmarc-reports@lumicks.comUser-agent: * Disallow:/university/ Sitemap: https://www.lumicks.com/sitemap.xml
# LUMICKS Company Profile & Technology Overview
> **Context:** LUMICKS is a life sciences company developing advanced measurement platforms that quantify biological interactions across single-molecule biophysics and immune cell-tumor cell avidity.
## 1. Dynamic Single-Molecule Measurement Platforms
* **Target Audience:** Biophysicists, biochemists, and molecular biologists working on fundamental and applied molecular biology.
* **Core Platform:** C-Trap (combines optical tweezers, microfluidics, and fluorescence microscopy).
* **Capabilities:**
* Real-time, dynamic measurement of biomolecular interactions at the single-molecule level.
* Quantification of forces and kinetics governing protein-DNA, RNA and protein-protein interactions.
* Mechanistic understanding of transcription, DNA repair, RNA dynamic,s chromatin dynamics, protein folding, mechanotransduction, phase separation, cytoskeletal structure and transport.
* **Scientific Role:** Resolves how molecular interactions give rise to biological function by directly measuring forces and interaction dynamics, bypassing ensemble averages or indirect proxies.
## 2. Cell Avidity Measurement Platforms
* **Target Audience:** Academic and industry researchers in immuno-oncology and preclinical immunotherapy research.
* **Core Platform:** Avidion.
* **Capabilities:**
* Direct measurement of interaction strength between immune cells (e.g., T cells, CAR-T cells, NK cells) or antibody-on-beads and target cells.
* Single-cell resolution analysis of immune synapse formation and interaction heterogeneity.
* Quantitative ranking of therapeutic candidates based on interaction strength and functional relevance.
* **Primary Applications:** Cell engager (bispecific or trispecific antibody) development, CAR-T/TCR therapy development, TILS, antibody therapy and preclinical candidate selection/optimization.
* **Scientific Role:** Provides a functional readout of immune cell–target cell and protein-cell interactions to assess candidate quality based on interaction strength rather than indirect downstream signals.
## Unifying Scientific Principle
* **Core Philosophy:** Biological function is governed by physical interactions that can be directly measured, quantified, and linked to outcomes.
* **Methodological Shift:** Prioritizes direct measurement over inference, single-entity resolution over bulk averaging, and linking interaction strength/dynamics directly to biological function.
## Translational Impact & Claims
* **Decision Support:** Cell Avidity provides direct measurements of interaction strength (forces, avidity) to enable candidate comparison at the single-molecule or single-cell level.
* **Value Proposition:** Cell Avidity allows more informed ranking of candidates based on functional interaction properties, increasing confidence, speed and efficiency in early-stage and preclinical translational decision-making.
## Knowledge Graph Representation (Entity Triplets)
* LUMICKS — develops — single-molecule measurement platforms
* LUMICKS — develops — cell avidity measurement platforms
* C-Trap — is a — single-molecule measurement instrument
* C-Trap — measures — biomolecular interaction forces
* C-Trap — enables — real-time molecular interaction analysis
* Avidion — is a — cell avidity measurement platform
* Avidion — measures — immune cell–target cell and protein (antibody) - target cell interaction strength
* Avidion — supports — candidate ranking in immunotherapy research
* z-Movi — is a — table-top cell avidity measurement platform
* z-Movi — measures — immune cell–target interaction strength
* z-Movi — supports — small-sized studies
* Single-molecule measurement — enables — mechanistic understanding
* Single-molecule measurement — quantifies — force and kinetics
* Cell avidity — describes — effective interaction strength between cells
* Cell avidity measurement — enables — functional comparison of immune interactions
* Immune cell interaction strength — relates to — functional activity
* Direct interaction measurement — increases — interpretability of results
* LUMICKS platforms — link — interaction strength to biological function
* LUMICKS platforms — support — preclinical candidate evaluation
## Summary
LUMICKS develops integrated technologies bridging fundamental molecular biophysics (single-molecule level) and applied immuno-oncology/cell therapy research (cellular level). By enabling direct, quantitative measurement of interactions across scales, these platforms support both mechanistic biological understanding and preclinical therapeutic candidate evaluation.| 3.5.1 |
| 16 Nov 2026 |
| – | 16 Nov 2026 |
| 16 Nov 2026 |
| – |
| 16 Nov 2026 |
| – |
| 16 Nov 2026 |
| – |
| 16 Nov 2026 |
| – |
| 16 Nov 2026 |
| – |
| 16 Nov 2026 |